AbbVie Q1 earnings: Immunology still a powerhouse as Skyrizi, Rinvoq hit $5B combined
Title: AbbVie Continues Strong Performance in Q1 2025; Skyrizi and Rinvoq Achieve Combined Revenues of $5B Publication Date: 25th April 2025 In line with its boosted future sales predictions, AbbVie delivered robust results for the first quarter of 2025. As…